FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1520609538> ?p ?o ?g. }

• W1520609538 endingPage "2397" @default.
• W1520609538 startingPage "2387" @default.
• W1520609538 abstract "Statin therapy reduces low-density lipoprotein (LDL) cholesterol levels and the risk of cardiovascular events, but whether the addition of ezetimibe, a nonstatin drug that reduces intestinal cholesterol absorption, can reduce the rate of cardiovascular events further is not known.We conducted a double-blind, randomized trial involving 18,144 patients who had been hospitalized for an acute coronary syndrome within the preceding 10 days and had LDL cholesterol levels of 50 to 100 mg per deciliter (1.3 to 2.6 mmol per liter) if they were receiving lipid-lowering therapy or 50 to 125 mg per deciliter (1.3 to 3.2 mmol per liter) if they were not receiving lipid-lowering therapy. The combination of simvastatin (40 mg) and ezetimibe (10 mg) (simvastatin-ezetimibe) was compared with simvastatin (40 mg) and placebo (simvastatin monotherapy). The primary end point was a composite of cardiovascular death, nonfatal myocardial infarction, unstable angina requiring rehospitalization, coronary revascularization (≥30 days after randomization), or nonfatal stroke. The median follow-up was 6 years.The median time-weighted average LDL cholesterol level during the study was 53.7 mg per deciliter (1.4 mmol per liter) in the simvastatin-ezetimibe group, as compared with 69.5 mg per deciliter (1.8 mmol per liter) in the simvastatin-monotherapy group (P<0.001). The Kaplan-Meier event rate for the primary end point at 7 years was 32.7% in the simvastatin-ezetimibe group, as compared with 34.7% in the simvastatin-monotherapy group (absolute risk difference, 2.0 percentage points; hazard ratio, 0.936; 95% confidence interval, 0.89 to 0.99; P=0.016). Rates of prespecified muscle, gallbladder, and hepatic adverse effects and cancer were similar in the two groups.When added to statin therapy, ezetimibe resulted in incremental lowering of LDL cholesterol levels and improved cardiovascular outcomes. Moreover, lowering LDL cholesterol to levels below previous targets provided additional benefit. (Funded by Merck; IMPROVE-IT ClinicalTrials.gov number, NCT00202878.)." @default.
• W1520609538 created "2016-06-24" @default.
• W1520609538 creator A5080868210 @default.
• W1520609538 date "2015-06-18" @default.
• W1520609538 modified "2023-10-17" @default.
• W1520609538 title "Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes" @default.
• W1520609538 cites W137344628 @default.
• W1520609538 cites W1498903994 @default.
• W1520609538 cites W1500963439 @default.
• W1520609538 cites W1856460279 @default.
• W1520609538 cites W1981798840 @default.
• W1520609538 cites W2018711158 @default.
• W1520609538 cites W2027316231 @default.
• W1520609538 cites W2031185570 @default.
• W1520609538 cites W2031600453 @default.
• W1520609538 cites W2040462758 @default.
• W1520609538 cites W2052094004 @default.
• W1520609538 cites W2080945076 @default.
• W1520609538 cites W2100800328 @default.
• W1520609538 cites W2103108681 @default.
• W1520609538 cites W2106343349 @default.
• W1520609538 cites W2107295258 @default.
• W1520609538 cites W2115012618 @default.
• W1520609538 cites W2118667643 @default.
• W1520609538 cites W2118825330 @default.
• W1520609538 cites W2129750583 @default.
• W1520609538 cites W2135631433 @default.
• W1520609538 cites W2139168645 @default.
• W1520609538 cites W2141079535 @default.
• W1520609538 cites W2147270034 @default.
• W1520609538 cites W2150799450 @default.
• W1520609538 cites W2151969933 @default.
• W1520609538 cites W2155598961 @default.
• W1520609538 cites W2156880046 @default.
• W1520609538 cites W2159449551 @default.
• W1520609538 cites W2164089346 @default.
• W1520609538 cites W2164324917 @default.
• W1520609538 cites W2165605025 @default.
• W1520609538 cites W2169523655 @default.
• W1520609538 cites W2247997571 @default.
• W1520609538 cites W2322095705 @default.
• W1520609538 cites W2478496979 @default.
• W1520609538 cites W3021842026 @default.
• W1520609538 cites W38523360 @default.
• W1520609538 cites W424467158 @default.
• W1520609538 doi "https://doi.org/10.1056/nejmoa1410489" @default.
• W1520609538 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26039521" @default.
• W1520609538 hasPublicationYear "2015" @default.
• W1520609538 type Work @default.
• W1520609538 sameAs 1520609538 @default.
• W1520609538 citedByCount "3107" @default.
• W1520609538 countsByYear W15206095382014 @default.
• W1520609538 countsByYear W15206095382015 @default.
• W1520609538 countsByYear W15206095382016 @default.
• W1520609538 countsByYear W15206095382017 @default.
• W1520609538 countsByYear W15206095382018 @default.
• W1520609538 countsByYear W15206095382019 @default.
• W1520609538 countsByYear W15206095382020 @default.
• W1520609538 countsByYear W15206095382021 @default.
• W1520609538 countsByYear W15206095382022 @default.
• W1520609538 countsByYear W15206095382023 @default.
• W1520609538 crossrefType "journal-article" @default.
• W1520609538 hasAuthorship W1520609538A5080868210 @default.
• W1520609538 hasBestOaLocation W15206095381 @default.
• W1520609538 hasConcept C126322002 @default.
• W1520609538 hasConcept C126894567 @default.
• W1520609538 hasConcept C142724271 @default.
• W1520609538 hasConcept C164705383 @default.
• W1520609538 hasConcept C168563851 @default.
• W1520609538 hasConcept C176674119 @default.
• W1520609538 hasConcept C203092338 @default.
• W1520609538 hasConcept C204243189 @default.
• W1520609538 hasConcept C204787440 @default.
• W1520609538 hasConcept C27081682 @default.
• W1520609538 hasConcept C2776329913 @default.
• W1520609538 hasConcept C2776839432 @default.
• W1520609538 hasConcept C2776999253 @default.
• W1520609538 hasConcept C2777698277 @default.
• W1520609538 hasConcept C2777785093 @default.
• W1520609538 hasConcept C2778163477 @default.
• W1520609538 hasConcept C2778657065 @default.
• W1520609538 hasConcept C500558357 @default.
• W1520609538 hasConcept C71924100 @default.
• W1520609538 hasConcept C90924648 @default.
• W1520609538 hasConceptScore W1520609538C126322002 @default.
• W1520609538 hasConceptScore W1520609538C126894567 @default.
• W1520609538 hasConceptScore W1520609538C142724271 @default.
• W1520609538 hasConceptScore W1520609538C164705383 @default.
• W1520609538 hasConceptScore W1520609538C168563851 @default.
• W1520609538 hasConceptScore W1520609538C176674119 @default.
• W1520609538 hasConceptScore W1520609538C203092338 @default.
• W1520609538 hasConceptScore W1520609538C204243189 @default.
• W1520609538 hasConceptScore W1520609538C204787440 @default.
• W1520609538 hasConceptScore W1520609538C27081682 @default.
• W1520609538 hasConceptScore W1520609538C2776329913 @default.
• W1520609538 hasConceptScore W1520609538C2776839432 @default.
• W1520609538 hasConceptScore W1520609538C2776999253 @default.
• W1520609538 hasConceptScore W1520609538C2777698277 @default.

• next